Luke Nordquist, MD, FACP, CEO
drluke@xcancer.comTony Romero, MS, CCRC, Director of Research
tromero@gucancer.comDescription:
Stimulator of interferon gene (STING) protein plays a vital role in the immune surveillance of tumor microenvironment. Monitoring STING expression in tumors benefits the relevant STING therapy. This study will investigate the safety, biodistribution and potential usefulness of a novel 68Ga-labeled agonist (\[68Ga\]Ga-Sa-DABI-4) for noninvasive positron emission tomography (PET) imaging of STING expression in the tumor microenvironment.
Sponsor:
First Affiliated Hospital of Chongqing Medical University
Phase:
Early Phase 1
Contacts:
Xiaoyang Zhang, PhD (CONTACT)zhangxy@mail.bnu.edu.cn
023-89011755
Government Study Link:
NCT06419361 - Click here to see study onClinicalTrials.gov
Exclusion Criteria Not Yet Provided
Help us improve your experience